A detailed history of Fred Alger Management, LLC transactions in Codexis, Inc. stock. As of the latest transaction made, Fred Alger Management, LLC holds 125,916 shares of CDXS stock, worth $580,472. This represents 0.0% of its overall portfolio holdings.

Number of Shares
125,916
Previous 349,490 63.97%
Holding current value
$580,472
Previous $1.08 Million 64.27%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.62 - $3.71 $585,763 - $829,459
-223,574 Reduced 63.97%
125,916 $387,000
Q2 2024

Aug 14, 2024

SELL
$2.65 - $3.92 $420,303 - $621,731
-158,605 Reduced 31.22%
349,490 $1.08 Million
Q1 2024

May 15, 2024

BUY
$2.59 - $4.65 $194,524 - $349,242
75,106 Added 17.35%
508,095 $1.77 Million
Q4 2023

Feb 14, 2024

BUY
$1.54 - $3.37 $666,803 - $1.46 Million
432,989 New
432,989 $1.32 Million

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $302M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.